These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23377183)

  • 21. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.
    Ma X; Edmonson M; Yergeau D; Muzny DM; Hampton OA; Rusch M; Song G; Easton J; Harvey RC; Wheeler DA; Ma J; Doddapaneni H; Vadodaria B; Wu G; Nagahawatte P; Carroll WL; Chen IM; Gastier-Foster JM; Relling MV; Smith MA; Devidas M; Guidry Auvil JM; Downing JR; Loh ML; Willman CL; Gerhard DS; Mullighan CG; Hunger SP; Zhang J
    Nat Commun; 2015 Mar; 6():6604. PubMed ID: 25790293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance revealed in acute lymphoblastic leukemia.
    Aster JC; DeAngelo DJ
    Nat Med; 2013 Mar; 19(3):264-5. PubMed ID: 23467232
    [No Abstract]   [Full Text] [Related]  

  • 23. NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.
    Elsaid MF; Ibrahim K; Chalhoub N; Elsotouhy A; El Mudehki N; Abdel Aleem A
    BMC Med Genet; 2017 Mar; 18(1):33. PubMed ID: 28327087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia.
    Jiang C; Yang W; Moriyama T; Liu C; Smith C; Yang W; Qian M; Li Z; Tulstrup M; Schmiegelow K; Crews KR; Zhang H; Pui CH; Evans W; Relling M; Bhatia S; Yang JJ
    Clin Pharmacol Ther; 2021 Jun; 109(6):1538-1545. PubMed ID: 33124053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic drivers of vulnerability and resistance in relapsed acute lymphoblastic leukemia.
    Lu SX; Abdel-Wahab O
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11071-11073. PubMed ID: 27663730
    [No Abstract]   [Full Text] [Related]  

  • 26. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.
    Blau O; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
    Leuk Res; 1997 Aug; 21(8):721-9. PubMed ID: 9379679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational profiling of acute lymphoblastic leukemia with testicular relapse.
    Ding LW; Sun QY; Mayakonda A; Tan KT; Chien W; Lin DC; Jiang YY; Xu L; Garg M; Lao ZT; Lill M; Yang H; Yeoh AE; Koeffler HP
    J Hematol Oncol; 2017 Mar; 10(1):65. PubMed ID: 28253933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation.
    Xiao H; Wang LM; Luo Y; Lai X; Li C; Shi J; Tan Y; Fu S; Wang Y; Zhu N; He J; Zheng W; Yu X; Cai Z; Huang H
    Oncotarget; 2016 Jan; 7(3):2696-708. PubMed ID: 26527318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors.
    Oh HR; Choi YJ; Yoo NJ; Lee SH
    Pathol Oncol Res; 2016 Jan; 22(1):223-4. PubMed ID: 26259531
    [No Abstract]   [Full Text] [Related]  

  • 30. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; Letouzé E; Berthier C; Yuan H; Jollivet F; Ades L; Cassinat B; Hirsch P; Pigneux A; Mozziconacci MJ; Kogan S; Fenaux P; de Thé H
    Nat Commun; 2018 May; 9(1):2047. PubMed ID: 29795382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
    Ma H; Qazi S; Ozer Z; Gaynon P; Reaman GH; Uckun FM
    Br J Haematol; 2012 Jan; 156(1):89-98. PubMed ID: 22017452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
    Waanders E; Gu Z; Dobson SM; Antić Ž; Crawford JC; Ma X; Edmonson MN; Payne-Turner D; van de Vorst M; Jongmans MCJ; McGuire I; Zhou X; Wang J; Shi L; Pounds S; Pei D; Cheng C; Song G; Fan Y; Shao Y; Rusch M; McCastlain K; Yu J; van Boxtel R; Blokzijl F; Iacobucci I; Roberts KG; Wen J; Wu G; Ma J; Easton J; Neale G; Olsen SR; Nichols KE; Pui CH; Zhang J; Evans WE; Relling MV; Yang JJ; Thomas PG; Dick JE; Kuiper RP; Mullighan CG
    Blood Cancer Discov; 2020 Jul; 1(1):96-111. PubMed ID: 32793890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia
    Saliba J; Evensen NA; Meyer JA; Newman D; Nersting J; Narang S; Ma X; Schmiegelow K; Carroll WL
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28306. PubMed ID: 32391957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
    Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
    Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
    Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia.
    Gump J; McGavran L; Wei Q; Hunger SP
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):416-9. PubMed ID: 11878574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.